Takahiro Nagata, Yasuaki Takeyama, Satoshi Shakado, Fumihito Hirai, Satoshi Nimura. Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases. Cureus. 2023. 15. 1. e34275
Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, et al. Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy. J Gastroenterol Hepatol. 2020
Kunimoto H, Shakado S, Tanaka T, Takata K, Yamauchi R, Fukuda H, Tsuchiya N, Yokoyama K, Morihara D, Takeyama Y, et al. Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma. Oncology. 2020. 2. 1-8
Tanaka T, Takata K, Kunimoto H, Fukuda H, Yamauchi R, Tsuchiya N, Inomata S, Yokoyama K, Morihara D, Takeyama Y, et al. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period. Oncology. 2020. 14. 1-10
Yokoyama K, Tsuchiya N, Yamauchi R, Miyayama T, Uchida Y, Shibata K, Fukuda H, Umeda K, Takata K, Tanaka T, et al. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension. Intern Med. 2020. 59. 17. 2089-2094
Tetsuro Sohda, Keiji Yokoyama, Eri Yamauchi, Akira Anan, Takashi Tanaka, Daisuke Morihara, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Shotaro Sakisaka. Efficacy of sofosbuvir and ledipasvir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2. HEPATOLOGY RESEARCH. 2017. 47. 13. 1494-1494
Takashi Tanaka, Akira Anan, Daisuke Morihara, Kazuhide Takata, Keiji Yokoyama, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka. The radiofrequency ablation is eligible treatment for the case of hepatocellular carcinoma more than 3 cm in diameter with Child-Pugh class A or des-gamma-carboxy prothrombin level less than 200 mAU/mL: Analysis of 1815 cases in a single center for fourteen-year experience. HEPATOLOGY. 2015. 62. 405A-405A
Kazuhide Takata, Akira Anan, Takashi Tanaka, Keiji Yokoyama, Daisuke Morihara, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Kaoru Iwata, Tetsuro Sohda, et al. Significant Suppression of Local Tumor Recurrence in Treatment for Hepatocellular Carcinoma with Peritumoral Vessels by Radiofrequency Ablation with Percutaneous Ethanol Injection: Propensity Score Matching Analysis. HEPATOLOGY. 2015. 62. 417A-417A
Hiroto Egawa, Shotaro Sakisaka, Yasuaki Takeyama, Masakazu Yamamoto. Impact of HLA Mismatch on Clinical Outcome after Living Donor Liver Transplantation for PBC: Japanese Multicenter Study. LIVER TRANSPLANTATION. 2014. 20. S265-S265
Kunitoshi Sakurai, Shotaro Sakisaka, Tetsuro Sohda, Satoshi Shakado, Kaoru Iwata, Makoto Irie, Yasuaki Takeyama, Daisuke Morihara, Keiji Yokoyama. Significant Suppression of Angiogenetic Cytokines by Additional Short-Term Administration of Sorafenib in Transarterial Chemoembolization for Hepatocellular Carcinoma. HEPATOLOGY. 2012. 56. 461A-461A
Synergistic effect of clostridium butyricum miyairi on rifaximin in mice model of non-alcoholic steatohepatitis by methionine choline-deficient diet
(THE DIGITAL INTERNATIONAL LIVER CONGRESS European Association for the Study of the Liver(EASL) 2020)
